Léo Delcombel

I lead the UK commercial launch of a new oncology drug at Roche, working across market access, medical affairs and KOL engagement. Before that I ran a product launch that took its UK market share from 3% to 25% in two years, and I%27ve led global launch strategy across 40+ markets from Roche%27s Basel HQ. I know how NICE and NHS commissioning actually work, not just the theory, and I%27ve built the stakeholder and KOL networks that come with it.

I%27d add most value to early or growth-stage biotech and health-tech companies preparing a UK or European launch, especially in oncology or rare disease: commercial strategy, market access planning, payer engagement, or getting ready to talk to clinicians and investors in the same room.